What is Immunovant, Inc. Common Stock's Market Cap?

Immunovant, Inc. Common Stock's Market Cap is $8.2B, based on as-reported figures from SEC (XBRL) filings.

What is Immunovant, Inc. Common Stock's Enterprise Value?

Immunovant, Inc. Common Stock's Enterprise Value is $7.4B, based on as-reported figures from SEC (XBRL) filings.

What is Immunovant, Inc. Common Stock's Net Income (TTM)?

Immunovant, Inc. Common Stock's Net Income (TTM) is -$538.2M, based on as-reported figures from SEC (XBRL) filings.

What is Immunovant, Inc. Common Stock's Diluted EPS (TTM)?

Immunovant, Inc. Common Stock's Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.

What is Immunovant, Inc. Common Stock's Net Debt?

Immunovant, Inc. Common Stock's Net Debt is -$797.8M, based on as-reported figures from SEC (XBRL) filings.

Immunovant, Inc. Common Stock (IMVT) Financial Statements

Immunovant, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00P5MC0R7

XNAS · usd

39.57▲ 0.32 (0.82%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close39.25

Day's Range38.34 – 40.56

52-Week Range14.58 – 45.42

Volume1.5M

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees362

ExchangeXNAS

Listed2019-06-21

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Immunovant, Inc. Common Stock (IMVT)

What is Immunovant, Inc. Common Stock's Market Cap?: Immunovant, Inc. Common Stock's Market Cap is $8.2B, based on as-reported figures from SEC (XBRL) filings.
What is Immunovant, Inc. Common Stock's Enterprise Value?: Immunovant, Inc. Common Stock's Enterprise Value is $7.4B, based on as-reported figures from SEC (XBRL) filings.
What is Immunovant, Inc. Common Stock's Net Income (TTM)?: Immunovant, Inc. Common Stock's Net Income (TTM) is -$538.2M, based on as-reported figures from SEC (XBRL) filings.
What is Immunovant, Inc. Common Stock's Diluted EPS (TTM)?: Immunovant, Inc. Common Stock's Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.
What is Immunovant, Inc. Common Stock's Net Debt?: Immunovant, Inc. Common Stock's Net Debt is -$797.8M, based on as-reported figures from SEC (XBRL) filings.